Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma. [electronic resource]
Producer: 20060112Description: 1569-73 p. digitalISSN:- 1042-8194
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cause of Death
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Lymphoma, B-Cell -- drug therapy
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Middle Aged
- Prednisone -- administration & dosage
- Remission Induction
- Rituximab
- Survival Analysis
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.